Mironid is delighted to announce that Prof Albert Ong DM MA FRCP, Professor of Renal Medicine, Department of Infection Immunity & Cardiovascular Disease, University of Sheffield has joined our Scientific Advisory Board.
Albert brings enormous experience of the molecular, cellular and clinical aspects of Autosomal Dominant Polycystic Kidney Disease (ADPKD) to aid Mironid’s ongoing efforts to develop selective activators of phosphodiesterase-4 (PDE4) long isoforms for the treatment of ADPKD. Albert is: Co-chair of the ADPKD in Europe Consortium; Vice-Chair of the UK Kidney Research Consortium (UKKRC) Clinical Study Group on Cystic Kidney Diseases; former Chair of the Renal Association International Committee and Faculty member of the European ADPKD Forum. He is also an external faculty member of the Mayo Translational PKD Centre and was a nominated clinical expert for the National Institute for Clinical Excellence (NICE) Technology Appraisal of Tolvaptan for ADPKD.
Please click here to go to the announcement.